tiprankstipranks
Trending News
More News >

Dr. Reddy’s Laboratories Allots Equity Shares Under ESOPs

Story Highlights
Dr. Reddy’s Laboratories Allots Equity Shares Under ESOPs

Don’t Miss TipRanks’ Half-Year Sale

Dr Reddy’s Laboratories ( (RDY) ) has shared an update.

On June 3, 2025, Dr. Reddy’s Laboratories announced the allotment of 57,840 equity shares to eligible employees who exercised their stock options under the company’s Employee Stock Options Scheme, 2002. This move is part of the company’s ongoing efforts to incentivize and retain talent, potentially enhancing employee satisfaction and aligning their interests with those of the company. The issuance of these shares, which are fully paid up at a par value of Re.1 each, increases the total issued share capital to Rs. 83,45,14,205, reflecting the company’s robust growth and commitment to employee engagement.

The most recent analyst rating on (RDY) stock is a Buy with a $18.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.

Spark’s Take on RDY Stock

According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.

Dr Reddy’s Laboratories receives a solid overall score due to its strong financial performance, especially in revenue growth and balance sheet stability. Technical indicators show positive momentum, although the stock is below its long-term average. Valuation is reasonable, but dividend yield is low. The recent earnings call was positive, highlighting growth and strategic advancements despite some market challenges.

To see Spark’s full report on RDY stock, click here.

More about Dr Reddy’s Laboratories

Dr. Reddy’s Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India. It operates in the healthcare industry, focusing on the development and manufacturing of generic medications, active pharmaceutical ingredients, and proprietary products. The company is listed on multiple stock exchanges, including the BSE, NSE, and NYSE, and is known for its commitment to providing affordable and innovative medicines.

Average Trading Volume: 2,055,866

Technical Sentiment Signal: Strong Buy

Current Market Cap: $12.13B

For a thorough assessment of RDY stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1